Please enable JavaScript to continue using this application.

Compare $CRVO vs $HOWL | Chartloom

Compare

$CRVO vs $HOWL

CervoMed Inc · Werewolf Therapeutics Inc

CRVO

CervoMed Inc

HOWL

Werewolf Therapeutics Inc

Compare $CRVO vs $HOWL

Comparing CervoMed Inc and Werewolf Therapeutics Inc

CRVOCervoMed Inc

HOWLWerewolf Therapeutics Inc

CRVOCervoMed Inc

Market cap

$44M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-95.7%

YTD performance

-58.7%

52W performance

-63.8%

FCF yield

-64.2%

HOWLWerewolf Therapeutics Inc

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

51.9%

52W performance

-47.9%

FCF yield

-63.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRVO

HOWL

Detailed metrics comparison

CRVO

CervoMed Inc

HOWL

Werewolf Therapeutics Inc

Market Cap

CRVO$44M

HOWL$48M

Enterprise Value

CRVO$21M

HOWL$26M

Price

CRVO$3.22

HOWL$0.98

P/E Ratio

CRVON/A

HOWLN/A

P/S Ratio

CRVO131.50x

HOWL2.27x

EV/Sales

CRVO63.70x

HOWL1.22x

EV/EBITDA

CRVO0.00x

HOWL0.00x

P/B Ratio

CRVO1.99x

HOWL2.77x

P/FCF Ratio

CRVON/A

HOWLN/A

EV/FCF

CRVO-0.75x

HOWL-0.85x

PEG Ratio

CRVON/A

HOWLN/A

Forward P/E (NTM)

CRVON/A

HOWLN/A

Forward P/S (NTM)

CRVON/A

HOWLN/A

Revenue (TTM)

CRVO$331K

HOWL$21M

Revenue Growth (YoY)

CRVO-95.7%

HOWLN/A

Forward Rev Growth

CRVO2153.6%

HOWL0.0%

Gross Margin (TTM)

CRVO0.0%

HOWL0.0%

Operating Margin (TTM)

CRVO0.0%

HOWL18.1%

EBITDA Margin (TTM)

CRVO-9406.8%

HOWL-104.4%

Net Margin (TTM)

CRVO-9160.8%

HOWL-164.8%

FCF Margin (TTM)

CRVO-8444.8%

HOWL-143.6%

Net Income (TTM)

CRVO$-30M

HOWL$-35M

FCF (TTM)

CRVO$-28M

HOWL$-30M

EPS (TTM)

CRVO-$2.96

HOWL-$0.71

ROE (TTM)

CRVO-15602.0%

HOWL-16698.0%

ROA (TTM)

CRVO-12834.0%

HOWL-5988.0%

ROIC (TTM)

CRVO-15602.0%

HOWL-8259.0%

Cash

CRVO$22M

HOWL$22M

Debt

CRVO$0

HOWL$0

Net Cash/Debt

CRVO$22M

HOWL$22M

Current Ratio (TTM)

CRVO8.57x

HOWL2.91x

Quick Ratio (TTM)

CRVO8.36x

HOWL2.80x

Debt/Equity (TTM)

CRVO0.00x

HOWL1.14x

Debt/Assets (TTM)

CRVO0.0%

HOWL0.0%

Interest Coverage (TTM)

CRVON/A

HOWLN/A

Net Debt/EBITDA (TTM)

CRVO0.00x

HOWL0.00x

Beta

CRVO-0.69

HOWL0.57

52W Performance

CRVO-63.8%

HOWL-47.9%

YTD Performance

CRVO-58.7%

HOWL51.9%

% from 52W High

CRVO-67.8%

HOWL-49.4%

% from 52W Low

CRVO51.2%

HOWL262.8%

Asset Turnover (TTM)

CRVO0.07x

HOWL0.87x

FCF Yield (TTM)

CRVO-64.2%

HOWL-63.3%

Earnings Yield (TTM)

CRVO-69.7%

HOWL-72.7%

Dividend Yield (TTM)

CRVON/A

HOWLN/A

Rule of 40

CRVO-8,540.5

HOWL-143.6

EV/GP/RG

CRVON/A

HOWLN/A

Ticker research

View CRVO research View HOWL research

Metric	CRVO CervoMed Inc	HOWL Werewolf Therapeutics Inc
Market & Valuation
Market Cap	$44M	$48M
Enterprise Value	$21M	$26M
Price	$3.22	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	131.50x	2.27x
EV/Sales	63.70x	1.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.99x	2.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-0.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$331K	$21M
Revenue Growth (YoY)	-95.7%	N/A
Forward Rev Growth	2153.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	18.1%
EBITDA Margin (TTM)	-9406.8%	-104.4%
Net Margin (TTM)	-9160.8%	-164.8%
FCF Margin (TTM)	-8444.8%	-143.6%
Net Income (TTM)	$-30M	$-35M
FCF (TTM)	$-28M	$-30M
EPS (TTM)	-$2.96	-$0.71
ROE (TTM)	-15602.0%	-16698.0%
ROA (TTM)	-12834.0%	-5988.0%
ROIC (TTM)	-15602.0%	-8259.0%
Financial Health
Cash	$22M	$22M
Debt	$0	$0
Net Cash/Debt	$22M	$22M
Current Ratio (TTM)	8.57x	2.91x
Quick Ratio (TTM)	8.36x	2.80x
Debt/Equity (TTM)	0.00x	1.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.69	0.57
52W Performance	-63.8%	-47.9%
YTD Performance	-58.7%	51.9%
% from 52W High	-67.8%	-49.4%
% from 52W Low	51.2%	262.8%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.87x
FCF Yield (TTM)	-64.2%	-63.3%
Earnings Yield (TTM)	-69.7%	-72.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,540.5	-143.6
EV/GP/RG	N/A	N/A
Ticker research	View CRVO research	View HOWL research

Valuation

P/S Ratio

HOWL

2.27x

CRVO

131.50x

EV/FCF

HOWL

-0.85x

CRVO

-0.75x

Growth & revenue

Revenue Growth TTM

CRVO

-95.7%

Forward Revenue Growth

CRVO

2153.6%

HOWL

0.0%

Profitability & performance

Gross Margin

CRVO

0.0%

HOWL

0.0%

ROE

CRVO

-15602.0%

HOWL

-16698.0%

FCF Yield %

HOWL

-63.3%

CRVO

-64.2%

52-Week Performance

HOWL

-47.9%

CRVO

-63.8%

Detailed metrics comparison

CRVO

CervoMed Inc

HOWL

Werewolf Therapeutics Inc

Market Cap

CRVO$44M

HOWL$48M

Enterprise Value

CRVO$21M

HOWL$26M

Price

CRVO$3.22

HOWL$0.98

P/E Ratio

CRVON/A

HOWLN/A

P/S Ratio

CRVO131.50x

HOWL2.27x

EV/Sales

CRVO63.70x

HOWL1.22x

EV/EBITDA

CRVO0.00x

HOWL0.00x

P/B Ratio

CRVO1.99x

HOWL2.77x

P/FCF Ratio

CRVON/A

HOWLN/A

EV/FCF

CRVO-0.75x

HOWL-0.85x

PEG Ratio

CRVON/A

HOWLN/A

Forward P/E (NTM)

CRVON/A

HOWLN/A

Forward P/S (NTM)

CRVON/A

HOWLN/A

Revenue (TTM)

CRVO$331K

HOWL$21M

Revenue Growth (YoY)

CRVO-95.7%

HOWLN/A

Forward Rev Growth

CRVO2153.6%

HOWL0.0%

Gross Margin (TTM)

CRVO0.0%

HOWL0.0%

Operating Margin (TTM)

CRVO0.0%

HOWL18.1%

EBITDA Margin (TTM)

CRVO-9406.8%

HOWL-104.4%

Net Margin (TTM)

CRVO-9160.8%

HOWL-164.8%

FCF Margin (TTM)

CRVO-8444.8%

HOWL-143.6%

Net Income (TTM)

CRVO$-30M

HOWL$-35M

FCF (TTM)

CRVO$-28M

HOWL$-30M

EPS (TTM)

CRVO-$2.96

HOWL-$0.71

ROE (TTM)

CRVO-15602.0%

HOWL-16698.0%

ROA (TTM)

CRVO-12834.0%

HOWL-5988.0%

ROIC (TTM)

CRVO-15602.0%

HOWL-8259.0%

Cash

CRVO$22M

HOWL$22M

Debt

CRVO$0

HOWL$0

Net Cash/Debt

CRVO$22M

HOWL$22M

Current Ratio (TTM)

CRVO8.57x

HOWL2.91x

Quick Ratio (TTM)

CRVO8.36x

HOWL2.80x

Debt/Equity (TTM)

CRVO0.00x

HOWL1.14x

Debt/Assets (TTM)

CRVO0.0%

HOWL0.0%

Interest Coverage (TTM)

CRVON/A

HOWLN/A

Net Debt/EBITDA (TTM)

CRVO0.00x

HOWL0.00x

Beta

CRVO-0.69

HOWL0.57

52W Performance

CRVO-63.8%

HOWL-47.9%

YTD Performance

CRVO-58.7%

HOWL51.9%

% from 52W High

CRVO-67.8%

HOWL-49.4%

% from 52W Low

CRVO51.2%

HOWL262.8%

Asset Turnover (TTM)

CRVO0.07x

HOWL0.87x

FCF Yield (TTM)

CRVO-64.2%

HOWL-63.3%

Earnings Yield (TTM)

CRVO-69.7%

HOWL-72.7%

Dividend Yield (TTM)

CRVON/A

HOWLN/A

Rule of 40

CRVO-8,540.5

HOWL-143.6

EV/GP/RG

CRVON/A

HOWLN/A

Ticker research

View CRVO research View HOWL research

Metric	CRVO CervoMed Inc	HOWL Werewolf Therapeutics Inc
Market & Valuation
Market Cap	$44M	$48M
Enterprise Value	$21M	$26M
Price	$3.22	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	131.50x	2.27x
EV/Sales	63.70x	1.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.99x	2.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-0.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$331K	$21M
Revenue Growth (YoY)	-95.7%	N/A
Forward Rev Growth	2153.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	18.1%
EBITDA Margin (TTM)	-9406.8%	-104.4%
Net Margin (TTM)	-9160.8%	-164.8%
FCF Margin (TTM)	-8444.8%	-143.6%
Net Income (TTM)	$-30M	$-35M
FCF (TTM)	$-28M	$-30M
EPS (TTM)	-$2.96	-$0.71
ROE (TTM)	-15602.0%	-16698.0%
ROA (TTM)	-12834.0%	-5988.0%
ROIC (TTM)	-15602.0%	-8259.0%
Financial Health
Cash	$22M	$22M
Debt	$0	$0
Net Cash/Debt	$22M	$22M
Current Ratio (TTM)	8.57x	2.91x
Quick Ratio (TTM)	8.36x	2.80x
Debt/Equity (TTM)	0.00x	1.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.69	0.57
52W Performance	-63.8%	-47.9%
YTD Performance	-58.7%	51.9%
% from 52W High	-67.8%	-49.4%
% from 52W Low	51.2%	262.8%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.87x
FCF Yield (TTM)	-64.2%	-63.3%
Earnings Yield (TTM)	-69.7%	-72.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,540.5	-143.6
EV/GP/RG	N/A	N/A
Ticker research	View CRVO research	View HOWL research